Fundraising FoxNobiastx
1 known investors
Find your way into Nobiastx
214 people in our graph can introduce you to the Nobiastx team.
Sign up to see every warm intro you have to Nobiastx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nobiastx team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nobias Therapeutics is a clinical-stage drug developer creating small-molecule therapeutics for genetically-defined rare diseases, initially focused on pediatric indications with potential expansion into adult and non-rare conditions. It uses genomic and health datasets alongside relationships with pediatric academic medical centers across North America to advance drug discovery.
Founders & leadership
Investors · 1
How we know: Medical Excellence Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Related companies · 2
Companies working in the same space as Nobiastx.
Frequently asked questions
- What does Nobiastx do?
- Nobias Therapeutics is a clinical-stage drug developer creating small-molecule therapeutics for genetically-defined rare diseases, initially focused on pediatric indications with potential expansion into adult and non-rare conditions. It uses genomic and health datasets alongside relationships with pediatric academic medical centers across North America to advance drug discovery.
- Who founded Nobiastx?
- Nobiastx was founded by Hakon Hakonarson, Brian Halak.
- Who are Nobiastx's investors?
- Nobiastx's investors include Medical Excellence Capital.